Matthew Mansh
NPI 1760879654 · Dermatology Physician · Minneapolis, MN
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Matthew Mansh is a Dermatology Physician provider in Minneapolis, MN (NPI 1760879654).
Provider details
- NPI number
- 1760879654
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Sex
- Male
- Sole proprietor
- No
- License
- 65551 (MN)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
11 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
3,245 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,213 | $6 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 421 | $131 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 291 | $62 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 178 | $95 |
| Destruction of Skin Growth, 1-14 Growths17110 | 165 | $117 |
| Biopsy of Related Skin Growth, First Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 35 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 193 | 105 |
| Ketoconazole | 139 | 69 |
| Dupilumabbrand: Dupixent Pen | 89 | 19 |
| Fluocinonide | 76 | 32 |
| Tacrolimus | 67 | 47 |
| Clobetasol Propionate | 57 | 35 |
| Fluorouracil | 50 | 40 |
| Calcipotriene | 42 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2015-04-20
- Last updated
- 2019-09-03
Frequently asked questions
- What is Matthew Mansh's NPI number?
- Matthew Mansh's National Provider Identifier (NPI) is 1760879654, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Matthew Mansh's specialty?
- Matthew Mansh is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Matthew Mansh located?
- Matthew Mansh's practice location on file with NPPES is 2450 Riverside Ave, Minneapolis, MN 55454-1450.
- What is Matthew Mansh's phone number?
- The practice phone number listed in the NPPES registry for Matthew Mansh is (612) 672-6000.
- Does Matthew Mansh accept Medicare?
- Matthew Mansh is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Matthew Mansh's NPI active?
- Yes — Matthew Mansh's NPI (1760879654) is active in the NPPES registry as of the last update on 2019-09-03.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.